Navigation Links
Comment of Senator Patrick Leahy on President Obama's Decision to Reverse The 'Mexico City' Policy
Date:1/23/2009

WASHINGTON, Jan. 23 /PRNewswire-USNewswire/ -- The following is a statement by Senator Patrick Leahy, D-Vt., Chairman, U.S. Senate Subcommittee on State Department And Foreign Operations:

"President Obama has lifted a misguided, counterproductive and discriminatory policy that harms many and helps no one. This will enable us to help women space births and reduce infant mortality, while preventing abortions, unwanted pregnancies and pregnancy-related deaths, without a single taxpayer dollar being used for abortion. I hope this first step leads to a broader strategy to improve living standards in the world's poorest regions through family planning, maternal and child health care, and promoting adoption of orphans and abandoned children."


'/>"/>
SOURCE Office of U.S. Senator Patrick Leahy
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. APA Comments on FDAs First Approval of Medication to Treat Pediatric Schizophrenia and Bipolar Disorder
2. Comment Regarding Congregation for the Doctrine of Faith Clarification Concerning Nutrition and Hydration for Patients in a Persistent Vegetative State
3. Experts, Advocates Available to Comment on Hillary Clintons Health Care Plan
4. QMed, Inc. Comments on Estimated 3rd Quarter Results & Medical Expense Ratio; Sets 2008 Revenue Guidance for Medicare SNPs at $88-95 Million
5. The Branded Pharmaceutical Association Comments on Hydrocodone
6. Wyeth Comments on PREVNAR and Trends in Pneumococcal Disease
7. Bioniche Receives Comment from USDA on a Field Trial for E. coli O157:H7 Cattle Vaccine
8. Media Advisory - Bioniche Discusses USDA Comment on E. coli O157:H7 Cattle Vaccine Field Trial
9. Dr. Stephen Paget, Physician-in-Chief and Chairman, Division of Rheumatology, at Hospital for Special Surgery is Available to Comment on a Recent CDC Study on the Impact of Arthritis in the Work Place
10. Pelosi Statement on Stark Comments
11. Center for Consumer Freedom Spokesman Available for Comment on AICR International Cancer Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... ... ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, has published a ... an astounding statement when he says that the entire Bible was written for the ... times so plainly that anyone should be able to see the time period. He ...
(Date:2/24/2017)... ... February 24, 2017 , ... ... which specializes in thought leadership , media relations, social media, content marketing ... that will be powered through Act-On, an intuitive marketing automation platform. , Rosica ...
(Date:2/23/2017)... ... February 23, 2017 , ... On February 22, ... a letter to withdraw previous guidance issued by the Obama Administration requiring ... issued in May 2016 by the Obama Administration came in response to a ...
(Date:2/23/2017)... ... February 23, 2017 , ... The American Cleft Palate-Craniofacial Association (ACPA) is pleased ... KLS is a longtime supporter of the event. , "We are pleased that KLS ... Dr. Bob Havlik, 2017 ACPA President. "KLS Martin has a long track record of ...
(Date:2/23/2017)... ... February 23, 2017 , ... EBSCO Information Services ... Institute for Health and Care Excellence (NICE) framework. The agreement allows purchasers ... (NHS) to search, order and purchase medical and healthcare-related content through GOBI ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... Md. , Feb. 23, 2017 ... marketing of the PhenoTest BC Kit, performed on ... to identify organisms that cause bloodstream infections and ... likely to respond to (antibiotic sensitivity). The test ... to provide this important information, which can guide ...
(Date:2/24/2017)... 24 février 2017 ITL Limited, ( ASX : ITD ), ... ravie d,annoncer les excellents résultats semestriels clos le 31 ... Une présentation complète « Résultats et mise à jour sur ... . Faits marquants ... 1,04 million $ ; en hausse de 104 %) ...
(Date:2/24/2017)... 23, 2017 Non-alcoholic steatohepataitis (NASH) ... various drugs being developed for the treatment ... drugs that are in various phases of ... focuses on novel pharmacologic drugs & regenerative ... therapies, recombinant proteins and RNA-based therapeutics, but ...
Breaking Medicine Technology: